Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Shmeylan Al Harbi PharmD"'
Autor:
Raed Kensara BSc.Pharm, SCC-CCP, BCPS, Ohoud Aljuhani PharmD, Ghazwa B Korayem PharmD, Hadeel Alkofide PhD, Sumaya N Almohareb PharmD, Yousef S Alosaimi PharmD, Ali F Altebainawi PharmD, Khalid Bin saleh PharmD, Norah Al Andas PharmD, MClinPharm, Shmeylan Al Harbi PharmD, Abdullah F Al Harthi PharmD, BCCCP, Uhood Ashkan PharmD, Rema Alghamdi PharmD, Hisham A Badreldin PharmD, Awatif Hafiz PharmD, Mashael AlFaifi PharmD, Rahaf A Alqahtani PharmD, Ramesh Vishwakarma PhD, Abeer A Alenazi PharmD, Mai Alalawi PharmD, Reem mahboob BSc.pharm, Renad A Alfouzan PharmD, Layan B Al Tuhayni PharmD, Nouf Al Qahtani BSc.pharm, MSc Med. Ed, Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
Atrial fibrillation (Afib) can contribute to a significant increase in mortality and morbidity in critically ill patients. Thus, our study aims to investigate the incidence and clinical outcomes associated with the new-onset Afib in critically ill pa
Externí odkaz:
https://doaj.org/article/1ccd8ccd0378447f876bc769638f9f11
